Adverse events: Movement disorder ‐ any extra pyramidal symptoms ‐ short term · patients with schizophrenia
RISPERIDONE DEPOT showed no clear difference in adverse events: Movement disorder ‐ any extra pyramidal symptoms ‐… compared with ORAL RISPERIDONE (moderate certainty).
1 finding from 1 review
Weight gain · patients with schizophrenia
1 finding from 1 review
Leaving the study early · patients with schizophrenia
It is very uncertain whether RISPERIDONE DEPOT changes leaving the study early: Any reason ‐ all doses risperidone depot ‐… compared with PLACEBO (very low certainty).
1 finding from 1 review
Adverse events: General: Severe adverse event ‐ any dose risperidone depot ‐ short term Spontaneous reporting by study participants · patients with schizophrenia
It is very uncertain whether RISPERIDONE DEPOT changes adverse events: General: Severe adverse event ‐ any dose risperidone… compared with PLACEBO (very low certainty).
1 finding from 1 review
Adverse events: Specific: Weight gain ‐ all doses of depot risperidone ‐ short term Spontaneous reporting by study participants · patients with schizophrenia
It is very uncertain whether RISPERIDONE DEPOT changes adverse events: Specific: Weight gain ‐ all doses of depot… compared with PLACEBO (very low certainty).
1 finding from 1 review
Adverse events: General: Severe adverse event ‐ any dose risperidone depot ‐ short term · patients with schizophrenia
1 finding from 1 review
Complete or partial remission · patients with oesophageal cancer
Active cancer therapy combined with TCM probably leads to higher short‐term therapeutic effects ‐ improvement (complete response +… compared with active cancer therapy (moderate certainty).
1 finding from 1 review
Short‐term therapeutic effects ‐ progressive disease · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in short‐term therapeutic effects ‐ progressive disease compared with active cancer therapy (low certainty).
1 finding from 1 review
Intervention not reported
Pain intensity (VAS) short term · patients with chronic mechanical neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Disability (neck and pain disability scale) short term · patients with chronic neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Quality of life (SF‐36 mental score) short term · patients with chronic neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Disability (NPQ) short term · patients with chronic mechanical neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Disability (NDI) short term · patients with chronic mechanical neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Quality of life (SF‐36) short term · patients with chronic mechanical neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Pain intensity (VAS) short term · patients with chronic neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Pain pressure threshold short term · patients with chronic neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Disability (NDI) short term Function (NPQ) short term · patients with chronic neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Quality of life (SF‐36, Functional Component) short term · patients with chronic neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Pain intensity (VAS) short term · patients with chronic neck pain (pain for more than 90 days)
1 finding from 1 review
Intervention not reported
Cannabis use frequency at short‐term · adults with cannabis use disorder or frequent cannabis use
The intervention probably leads to higher cannabis use frequency at short‐term (moderate certainty).
1 finding from 1 review